Age-based (<65 vs ≥65 years) incidence of infections and serious infections with tofacitinib versus biological DMARDs in rheumatoid arthritis clinical trials and the US Corrona RA registry

Kevin L. Winthrop, Gustavo Citera, David Gold, Dan Henrohn, Carol A. Connell, Andrea B. Shapiro, Harry Shi, Alina M. Onofrei, Dimitrios A. Pappas, Hendrik Schulze-Koops

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)134-136
Number of pages3
JournalAnnals of the rheumatic diseases
Volume80
Issue number1
DOIs
StatePublished - Jan 1 2021

Keywords

  • adalimumab
  • antirheumatic agents
  • arthritis
  • biological therapy
  • rheumatoid
  • tumor necrosis factor inhibitors

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this